main power usa, inc.

873 broadway
new york, new york, 10003

NYS Entity Status
ACTIVE

NYS Filing Date
NOVEMBER 14, 2013

NYS DOS ID#
4487310

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - MAIN POWER USA, INC.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Coach Inc. is changing its name, and shoppers are pissed
    By Reuters - Wednesday Oct 11, 2017

    Coach Inc will change its corporate name to Tapestry Inc, it said on Wednesday, as it creates a broader umbrella for its high-end brands without diluting the iconic name known mainly for selling luxury handbags. The company’s shares were down 2 percent in early trading following the announcement in which Tapestry will be the holding...

    Source: New York Post: Business
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • Nathan Myhrvold: The Full Xconomy Voices Interview
    By Wade Roush - Friday Sep 22, 2017

    Episode 3 of our new podcast, Xconomy Voices, features a conversation about nuclear power with Nathan Myhrvold, the founder and CEO of Intellectual Ventures. The former Microsoft chief technology officer is now vice chairman of TerraPower, a Bellevue, WA-based spinout of Intellectual Ventures that aims to revive commercial nuclear energy. The company is researching next-generation […]

    Source: Xconomy New York
  • Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists
    By Corie Lok - Monday Aug 28, 2017

    It’s clear at this point that patients are no longer just subjects in clinical trials. Thanks to the growing power of patient advocacy groups—and an FDA eager to hear their perspective—patients and drug developers are increasingly finding creating ways to work together, as we’ve seen with the four finalists in the Patient Partnership category of […]

    Source: Xconomy New York